Browse by category

Palatin Technologies has completed its Phase 2 BMT-801 clinical study of the co-administration of MC4R bremelanotide + GLP-1/GIP...

Wave Life Sciences has announced clinical trial application (CTA) approval and initiation of the Phase 1 INLIGHT clinical trial of...

The American Diabetes Association (ADA) has announced a new suite of resources to support improved care for those living with obesity....

Despite the improvements in physical and mental health after bariatric and metabolic (BMS) procedures there is a possibility of a...

Researchers from Peking University, China, have revealed a sharp rise in the burden of early-onset type 2 diabetes mellitus (T2DM) among...

Rani Therapeutics has revealed new pharmacokinetic (PK) and pharmacodynamic (PD) data from a preclinical study evaluating the oral...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Healthcare professionals should be aware of the potential risk of pulmonary aspiration in patients using GLP-1 or dual GIP/GLP-1 receptor...

A recent study that used an innovative method for analysing body composition using advanced 3D imaging and deep learning techniques, has...

Fractyl Health is prioritising its REMAIN-1 pivotal study, addressing the demand for an off-ramp to GLP-1 drugs, while advancing its...